TrialArthritis research & therapy2016

Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK).

Ruediger B Mueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.